Reese T. Jones, M.D. - Publications

Affiliations: 
Psychiatry University of California, San Francisco, San Francisco, CA 
Area:
Drugs of abuse

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, et al. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discovery. PMID 26410082 DOI: 10.1158/2159-8290.CD-15-0369  0.52
2014 Shankar GM, Taylor-Weiner A, Lelic N, Jones RT, Kim JC, Francis JM, Abedalthagafi M, Borges LF, Coumans JV, Curry WT, Nahed BV, Shin JH, Paek SH, Park SH, Stewart C, et al. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathologica Communications. 2: 167. PMID 25589003 DOI: 10.1186/s40478-014-0167-x  0.52
2012 . Butterfly genome reveals promiscuous exchange of mimicry adaptations among species. Nature. 487: 94-8. PMID 22722851 DOI: 10.1038/nature11041  0.52
2011 Herbst ED, Harris DS, Everhart ET, Mendelson J, Jacob P, Jones RT. Cocaethylene formation following ethanol and cocaine administration by different routes. Experimental and Clinical Psychopharmacology. 19: 95-104. PMID 21463066 DOI: 10.1037/a0022950  0.52
2009 Harris DS, Everhart T, Jacob P, Lin E, Mendelson JE, Jones RT. A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. Bmc Clinical Pharmacology. 9: 13. PMID 19646280 DOI: 10.1186/1472-6904-9-13  0.52
2008 Mendelson JE, McGlothlin D, Harris DS, Foster E, Everhart T, Jacob P, Jones RT. The clinical pharmacology of intranasal l-methamphetamine. Bmc Clinical Pharmacology. 8: 4. PMID 18644153 DOI: 10.1186/1472-6904-8-4  0.52
2006 Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones RT. Human pharmacology of the methamphetamine stereoisomers. Clinical Pharmacology and Therapeutics. 80: 403-20. PMID 17015058 DOI: 10.1016/j.clpt.2006.06.013  0.52
2005 Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Repeated psychological stress testing in stimulant-dependent patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 669-77. PMID 15913869 DOI: 10.1016/j.pnpbp.2005.04.012  0.52
2004 Uemura N, Nath RP, Harkey MR, Henderson GL, Mendelson J, Jones RT. Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. Journal of Analytical Toxicology. 28: 253-9. PMID 15189676  0.52
2004 Harris DS, Mendelson JE, Lin ET, Upton RA, Jones RT. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. Clinical Pharmacokinetics. 43: 329-40. PMID 15080765 DOI: 10.2165/00003088-200443050-00005  0.52
2003 Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug and Alcohol Dependence. 72: 169-82. PMID 14636972 DOI: 10.1016/S0376-8716(03)00200-X  0.52
2003 Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones RT. The bioavailability of intranasal and smoked methamphetamine. Clinical Pharmacology and Therapeutics. 74: 475-86. PMID 14586388 DOI: 10.1016/j.clpt.2003.08.002  0.52
2003 Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1677-84. PMID 12813474 DOI: 10.1038/sj.npp.1300223  0.52
2003 Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Drug and Alcohol Dependence. 70: S29-37. PMID 12738348 DOI: 10.1016/S0376-8716(03)00057-7  0.52
2002 Lester L, Uemura N, Ademola J, Harkey MR, Nath RP, Kim SJ, Jerschow E, Henderson GL, Mendelson J, Jones RT. Disposition of cocaine in skin, interstitial fluid, sebum, and stratum corneum. Journal of Analytical Toxicology. 26: 547-53. PMID 12501911  0.52
2002 Jones RT. Cardiovascular system effects of marijuana. Journal of Clinical Pharmacology. 42: 58S-63S. PMID 12412837  0.52
2002 Jacob P, Wilson M, Yu L, Mendelson J, Jones RT. Determination of 4-hydroxy-3-methoxyphenylethylene glycol 4-sulfate in human urine using liquid chromatography-tandem mass spectrometry. Analytical Chemistry. 74: 5290-6. PMID 12403583 DOI: 10.1021/ac020101a  0.52
2002 Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology. 162: 396-405. PMID 12172693 DOI: 10.1007/s00213-002-1131-1  0.52
2002 Delucchi KL, Batki SL, Moon J, Jacob P, Jones RT. Urine toxicology samples in cocaine treatment trials: how many need to be tested? Journal of Addictive Diseases. 21: 17-26. PMID 11916369 DOI: 10.1300/J069v21n02_02  0.52
2001 Vollenweider FX, Jones RT, Baggott MJ. Caveat emptor: editors beware. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 461-3. PMID 11310414 DOI: 10.1016/S0893-133X(00)00170-6  0.48
2000 Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Annals of Internal Medicine. 133: 969-73. PMID 11119398  0.52
2000 Harris D, Jones RT, Shank R, Nath R, Fernandez E, Goldstein K, Mendelson J. Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. Journal of Addictive Diseases. 19: 89-103. PMID 11076122 DOI: 10.1300/J069v19n03_07  0.52
2000 Harris DS, Jones RT, Welm S, Upton RA, Lin E, Mendelson J. Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug and Alcohol Dependence. 61: 85-94. PMID 11064186 DOI: 10.1016/S0376-8716(00)00126-5  0.52
2000 Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E, Zehnder J. Chemical analysis of ecstasy pills. Jama. 284: 2190. PMID 11056589  0.52
2000 Dempsey DA, Hajnal BL, Partridge JC, Jacobson SN, Good W, Jones RT, Ferriero DM. Tone abnormalities are associated with maternal cigarette smoking during pregnancy in in utero cocaine-exposed infants. Pediatrics. 106: 79-85. PMID 10878153  0.52
1999 Panganiban K, Jacob P, Everhart ET, Tisdale EC, Batki SL, Mendelson JE, Jones RT. Sulfonium salts as derivatizing agents. 3. Quantitation of the cocaine metabolite benzoylecgonine in urine using gas chromatography with ion-pair extraction/on-column alkylation. Journal of Analytical Toxicology. 23: 581-5. PMID 10595843  0.52
1999 Everhart ET, Shwonek P, Jacob P, Rowbotham MC, Jones RT. Quantitation of levorphanol in human plasma at subnanogram per milliliter levels using capillary gas chromatography with electron-capture detection. Journal of Chromatography. B, Biomedical Sciences and Applications. 729: 173-81. PMID 10410940 DOI: 10.1016/S0378-4347(99)00160-7  0.52
1999 Dempsey D, Jacob P, Partridge JC, Jones RT, Panganiban K, Rowbotham MC. Cocaine metabolite kinetics in the newborn. Journal of Analytical Toxicology. 23: 24-8. PMID 10022205  0.52
1999 Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers. Psychopharmacology. 141: 37-46. PMID 9952063 DOI: 10.1007/s002130050804  0.52
1999 Everhart ET, Jacob P, Mendelson J, Jones RT. The synthesis of deuterium-labelled cocaine, cocaethylene and metabolites Journal of Labelled Compounds and Radiopharmaceuticals. 42: 1265-1275. DOI: 10.1002/(SICI)1099-1344(19991230)42:13<1265::AID-JLCR283>3.0.CO;2-Y  0.52
1999 Everhart ET, Cheung P, Mendelson J, Upton R, Jones RT. The mass balance of buprenorphine in humans Clinical Pharmacology and Therapeutics. 65: 152.  0.52
1999 Mendelson J, Upton R, Lin E, Welm S, Jones RT. Dose proportionality of 4, 8, 16 and 32 MG sublingual buprenorphine solutions Clinical Pharmacology and Therapeutics. 65: 154.  0.52
1998 Dempsey DA, Partridge JC, Jones RT, Rowbotham MC. Cocaine, nicotine, caffeine, and metabolite plasma concentrations in neonates. Journal of Analytical Toxicology. 22: 220-4. PMID 9602939  0.52
1998 Henderson GL, Harkey MR, Zhou C, Jones RT, Jacob P. Incorporation of isotopically labeled cocaine into human hair: race as a factor. Journal of Analytical Toxicology. 22: 156-65. PMID 9547413  0.52
1997 Everhart ET, Cheung P, Shwonek P, Zabel K, Tisdale EC, Jacob P, Mendelson J, Jones RT. Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine. Clinical Chemistry. 43: 2292-302. PMID 9439446  0.52
1997 Delucchi KL, Jones RT, Batki SL. Measurement properties of quantitative urine benzoylecgonine in clinical trials research. Addiction (Abingdon, England). 92: 297-302. PMID 9219391 DOI: 10.1111/j.1360-0443.1997.tb03199.x  0.52
1997 Mendelson J, Jones RT, Welm S, Brown J, Batki SL. Buprenorphine and naloxone interactions in methadone maintenance patients. Biological Psychiatry. 41: 1095-101. PMID 9146820 DOI: 10.1016/S0006-3223(96)00266-1  0.52
1997 Mendelson J, Upton RA, Everhart ET, Jacob P, Jones RT. Bioavailability of sublingual buprenorphine. Journal of Clinical Pharmacology. 37: 31-7. PMID 9048270  0.52
1997 Jacob P, Mendelson J, Everhart ET, Nath R, Baggott M, Welm S, Jones RT. Formation and elimination of cocaethylene in humans Clinical Pharmacology and Therapeutics. 61: 222.  0.52
1997 Mendelson J, Upton R, Lin E, Welm S, Jones RT. Sublingual buprenorphine and naloxone interactions in opiate-dependent patients stabilized on buprenorphine Clinical Pharmacology and Therapeutics. 61: 191.  0.52
1997 Mendelson J, Jacob P, Nath RP, Welm S, Jones RT. Comparative pharmacology of methamphetamine and cocaine: Drug discrimination and physiologic effects Clinical Pharmacology and Therapeutics. 61: 191.  0.52
1996 Henderson GL, Harkey MR, Zhou C, Jones RT, Jacob P. Incorporation of isotopically labeled cocaine and metabolites into human hair: 1. dose-response relationships. Journal of Analytical Toxicology. 20: 1-12. PMID 8837944  0.52
1996 Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, Baggott MJ. Buprenorphine and naloxone interactions in opiate-dependent volunteers. Clinical Pharmacology and Therapeutics. 60: 105-14. PMID 8689806 DOI: 10.1016/S0009-9236(96)90173-3  0.52
1996 Eisenberg MJ, Yakel DL, Mendelson J, Redberg RF, Jones RT, Foster E. Immediate effects of intravenous cocaine on the thoracic aorta and coronary arteries. A transesophageal echocardiographic study. Chest. 110: 147-54. PMID 8681619  0.52
1995 Jacob P, Tisdale EC, Panganiban K, Cannon D, Zabel K, Mendelson JE, Jones RT. Gas chromatographic determination of methamphetamine and its metabolite amphetamine in human plasma and urine following conversion to N-propyl derivatives. Journal of Chromatography. B, Biomedical Applications. 664: 449-57. PMID 7780602 DOI: 10.1016/0378-4347(94)00479-O  0.52
1995 Mendelson J, Jones RT, Upton R, Jacob P. Methamphetamine and ethanol interactions in humans. Clinical Pharmacology and Therapeutics. 57: 559-68. PMID 7768079 DOI: 10.1016/0009-9236(95)90041-1  0.52
1995 Eisenberg MJ, Jue J, Mendelson J, Jones RT, Schiller NB. Left ventricular morphologic features and function in nonhospitalized cocaine users: a quantitative two-dimensional echocardiographic study. American Heart Journal. 129: 941-6. PMID 7732983 DOI: 10.1016/0002-8703(95)90115-9  0.52
1993 Eisenberg MJ, Mendelson J, Evans GT, Jue J, Jones RT, Schiller NB. Left ventricular function immediately after intravenous cocaine: a quantitative two-dimensional echocardiographic study. Journal of the American College of Cardiology. 22: 1581-6. PMID 8227824  0.52
1993 Stillman R, Jones RT, Moore D, Walker J, Welm S. Improved performance 4 hours after cocaine. Psychopharmacology. 110: 415-20. PMID 7870911 DOI: 10.1007/BF02244647  0.52
1991 Ellis WS, Jones RT. Using LabVIEW to facilitate calibration and verification for respiratory impedance plethysmography. Computer Methods and Programs in Biomedicine. 36: 169-75. PMID 1773604 DOI: 10.1016/0169-2607(91)90086-9  0.52
1990 Jones RT. The pharmacology of cocaine smoking in humans. Nida Research Monograph. 99: 30-41. PMID 2267012  0.52
1990 Batki SL, Manfredi LB, Sorensen JL, Jacob P, Dumontet R, Jones RT. Fluoxetine for cocaine abuse in methadone patients: preliminary findings. Nida Research Monograph. 105: 516-7. PMID 1876106  0.52
1988 Lim HK, Andrenyak D, Francom P, Foltz RL, Jones RT. Quantification of LSD and N-demethyl-LSD in urine by gas chromatography/resonance electron capture ionization mass spectrometry. Analytical Chemistry. 60: 1420-5. PMID 3218752  0.52
1987 Herning RI, Jones RT, Hunt JS. Speech event related potentials reflect linguistic content and processing level. Brain and Language. 30: 116-29. PMID 3815050 DOI: 10.1016/0093-934X(87)90032-0  0.52
1987 Jacob P, Elias-Baker BA, Jones RT, Benowitz NL. Determination of benzoylecgonine and cocaine in biologic fluids by automated gas chromatography. Journal of Chromatography. 417: 277-86. PMID 3654881 DOI: 10.1016/0378-4347(87)80121-4  0.52
1987 Hall SM, Tunstall CD, Ginsberg D, Benowitz NL, Jones RT. Nicotine gum and behavioral treatment: a placebo controlled trial. Journal of Consulting and Clinical Psychology. 55: 603-5. PMID 3624619  0.52
1987 Rowbotham MC, Hooker WD, Mendelson J, Jones RT. Cocaine-calcium channel antagonist interactions. Psychopharmacology. 93: 152-4. PMID 3122247  0.52
1987 Hooker WD, Jones RT. Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication. Psychopharmacology. 91: 20-4. PMID 3029792 DOI: 10.1007/BF00690920  0.52
1987 Herning RI, Hooker WD, Jones RT. Cocaine effects on electroencephalographic cognitive event-related potentials and performance. Electroencephalography and Clinical Neurophysiology. 66: 34-42. PMID 2431864 DOI: 10.1016/0013-4694(87)90136-2  0.52
1986 Benowitz NL, Jones RT, Jacob P. Additive cardiovascular effects of nicotine and ethanol. Clinical Pharmacology and Therapeutics. 40: 420-4. PMID 3757405  0.52
1986 Benowitz NL, Jacob P, Yu L, Talcott R, Hall S, Jones RT. Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow- but not low-yield cigarettes. Jama. 256: 241-6. PMID 3723711 DOI: 10.1001/jama.1986.03380020103032  0.52
1986 Hall SM, Ginsberg D, Jones RT. Smoking cessation and weight gain. Journal of Consulting and Clinical Psychology. 54: 342-6. PMID 3722562 DOI: 10.1037/0022-006X.54.3.342  0.52
1986 Herning RI, Hooker WD, Jones RT. Tetrahydrocannabinol content and differences in marijuana smoking behavior. Psychopharmacology. 90: 160-2. PMID 3024196 DOI: 10.1007/BF00181232  0.52
1985 Hall SM, Tunstall C, Rugg D, Jones RT, Benowitz N. Nicotine gum and behavioral treatment in smoking cessation. Journal of Consulting and Clinical Psychology. 53: 256-8. PMID 3998252 DOI: 10.1037/0022-006X.53.2.256  0.52
1985 Herning RI, Jones RT, Hooker WD, Tulunay FC. Information processing components of the auditory event related potential are reduced by cocaine. Psychopharmacology. 87: 178-85. PMID 3931143 DOI: 10.1007/BF00431804  0.52
1985 Herning RI, Jones RT, Hooker WD, Mendelson J, Blackwell L. Cocaine increases EEG beta: a replication and extension of Hans Berger's historic experiments. Electroencephalography and Clinical Neurophysiology. 60: 470-7. PMID 2408845 DOI: 10.1016/0013-4694(85)91106-X  0.52
1984 Hall SM, Herning RI, Jones RT, Benowitz NL, Jacob P. Blood cotinine levels as indicators of smoking treatment outcome. Clinical Pharmacology and Therapeutics. 35: 810-4. PMID 6734033  0.52
1984 Jacob P, Elias-Baker BA, Jones RT, Benowitz NL. Determination of cocaine in plasma by automated gas chromatography. Journal of Chromatography. 306: 173-81. PMID 6715457 DOI: 10.1016/S0378-4347(00)80880-4  0.52
1984 Hall SM, Rugg D, Tunstall C, Jones RT. Preventing relapse to cigarette smoking by behavioral skill training. Journal of Consulting and Clinical Psychology. 52: 372-82. PMID 6379002 DOI: 10.1037/0022-006X.52.3.372  0.52
1983 Herning RI, Jones RT, Benowitz NL, Mines AH. How a cigarette is smoked determines blood nicotine levels. Clinical Pharmacology and Therapeutics. 33: 84-90. PMID 6848303  0.52
1983 Benowitz NL, Kuyt F, Jacob P, Jones RT, Osman AL. Cotinine disposition and effects. Clinical Pharmacology and Therapeutics. 34: 604-11. PMID 6627820  0.52
1983 Hall SM, Bachman J, Henderson JB, Barstow R, Jones RT. Smoking cessation in patients with cardiopulmonary disease: an initial study. Addictive Behaviors. 8: 33-42. PMID 6349289 DOI: 10.1016/0306-4603(83)90053-9  0.52
1983 Rowbotham MC, Joseph MS, Jones RT, Keil LC. Failure of naloxone to reverse apomorphine effects in humans. Psychoneuroendocrinology. 8: 95-102. PMID 6308702 DOI: 10.1016/0306-4530(83)90045-8  0.52
1981 Hunt CA, Jones RT, Herning RI, Bachman J. Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man. Journal of Pharmacokinetics and Biopharmaceutics. 9: 245-60. PMID 6270295 DOI: 10.1007/BF01059266  0.52
1980 Peeke SC, Callaway E, Jones RT, Stone GC, Doyle J. Combined effects of alcohol and sleep deprivation in normal young adults Psychopharmacology. 67: 279-287. PMID 6770408 DOI: 10.1007/BF00431270  0.52
1979 Bachman J, Jones RT. Personality correlates of cannabis dependence. Addictive Behaviors. 4: 361-71. PMID 525504 DOI: 10.1016/0306-4603(79)90007-8  0.52
1979 Benowitz NL, Rosenberg J, Rogers W, Bachman J, Jones RT. Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clinical Pharmacology and Therapeutics. 25: 440-6. PMID 428189  0.52
1979 Herning RI, Jones RT, Peltzman DJ. Changes in human event related potentials with prolonged delta-9-tetrahydrocannabinol (THC) use Electroencephalography and Clinical Neurophysiology. 47: 556-570. PMID 91483 DOI: 10.1016/0013-4694(79)90257-8  0.52
1978 Adams AJ, Brown B, Haegerstrom-Portnoy G, Flom MC, Jones RT. Marijuana, alcohol, and combined drug effects on the time course of glare recovery Psychopharmacology. 56: 81-86. PMID 415330 DOI: 10.1007/BF00571413  0.52
1977 Benowitz NL, Jones RT. Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism Antipyrine, pentobarbital, and ethanol Clinical Pharmacology and Therapeutics. 22: 259-268. PMID 891094  0.52
1977 Benowitz NL, Jones RT. Prolonged delta-9-tetrahydrocannabinol ingestion Effects of sympathomimetic amines and autonomic blockades Clinical Pharmacology and Therapeutics. 21: 336-342. PMID 837652  0.52
1977 Brown B, Adams AJ, Haegerstrom-Portnoy G, Jones RT, Flom MC. Pupil size after use of marijuana and alcohol American Journal of Ophthalmology. 83: 350-354. PMID 322494  0.52
1976 Lau RJ, Tubergen DG, Barr M, Domino EF, Benowitz N, Jones RT. Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol. Science (New York, N.Y.). 192: 805-7. PMID 1265484  0.52
1976 Peeke SC, Jones RT, Stone GC. Effects of practice on marijuana-induced changes in reaction time Psychopharmacology. 48: 159-163. PMID 826928 DOI: 10.1007/BF00423255  0.52
1975 Benowitz NL, Jones RT. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion Clinical Pharmacology and Therapeutics. 18: 287-297. PMID 1164818  0.52
Show low-probability matches.